Pharma Excipients

News on Pharma Excipients

Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization

Abstract Breast cancer continues to pose a substantial global health challenge, emphasizing the critical need for the advancement of novel therapeutic approaches. Key players in the regulation of apoptosis, a fundamental process in cell death, are the B-cell lymphoma 2 (Bcl-2) family proteins, namely Bcl-2 and Bax. These proteins have garnered…

See the Galenic Laboratory at Armor Pharma

Since 2020, Armor Pharma has invested in a state-of-the-art galenic laboratory, reinforcing their expertise as a pharmaceutical lactose supplier. Watch the new video State-of-the-art Galenic Laboratory by Armor Pharma below:…

Pharma Acetates – by Kerry

Focused on quality for better health Pharma acetates are used across a range of pharma applications that require a focus on quality control and product excellence. Using pharma-grade raw materials, our range of Niacet acetates are…

Current State of Minitablet Product Design: A Review

Abstract Interest in minitablets (MTs) has grown exponentially over the last 20 years and especially the last decade, as evidenced by the number of publications cited in Scopus and PubMed. MTs offer significant opportunities for…

Sustainably sourced Squalene – by Croda

Non-shark derived, engineered by synthetic biology. Our pharmaceutical-grade Squalene has superior purity, naturally setting it apart on the market. An innovative alternative to shark-derived squalene using synthetic biology There…